Parotid Gland Tumors: Can Addition of Diffusion-weighted MR Imaging to Dynamic Contrast-enhanced MR Imaging Improve Diagnostic Accuracy in Characterization?

被引:216
作者
Yabuuchi, Hidetake [1 ]
Matsuo, Yoshio [1 ]
Kamitani, Takeshi [1 ]
Setoguchi, Taro [1 ]
Okafuji, Takashi [1 ]
Soeda, Hiroyasu [1 ]
Sakai, Shuji [2 ]
Hatakenaka, Masamitsu [1 ]
Nakashima, Torahiko [3 ]
Oda, Yoshinao [4 ]
Honda, Hiroshi [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka 8128582, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Higashi Ku, Fukuoka 8128582, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan
关键词
D O I
10.1148/radiol.2493072045
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To determine the value of adding diffusion-weighted (DW) magnetic resonance (MR) imaging to dynamic contrast material-enhanced MR imaging when distinguishing between benign and malignant parotid tumors. Materials and Methods: This retrospective study was approved by the institutional review board, and the informed consent requirement was waived. The authors analyzed MR images of 50 lesions ( 36 benign, 14 malignant) in 47 patients. DW MR imaging and dynamic contrast-enhanced MR imaging were performed in all patients. Time-intensity curve ( TIC) patterns were categorized as follows: type A, time to peak was more than 120 seconds; type B, time to peak was 120 seconds or less with high washout ratio (>= 30%); type C, time to peak was 120 seconds or less with low washout ratio (< 30%); and type D, flat. The apparent diffusion coefficient ( ADC) values were measured on DW MR images. Sensitivity, specificity, accuracy, and positive and negative predictive values were calculated for type A, B, and D tumors regarded as benign and for type C tumors regarded as malignant. On the basis of DW MR imaging results, ADC threshold values between pleomorphic adenomas and carcinomas and between Warthin tumors and carcinomas were selected. Diagnostic accuracy was compared before and after modification diagnosis referring to the ADC value obtained with the McNemar test. P < .05 was considered to indicate a significant difference. Results: ADC threshold values were 1.4 x 10(-3) mm(2)/sec between pleomorphic adenomas and carcinomas and 1.0 x 10(-3) mm2/sec between Warthin tumors and carcinomas. Accuracy (82% vs 94%) and positive predictive value (67% vs 92%) significantly improved with the addition of ADC values in the evaluation of patients with type B or C tumors. Conclusion: A persistent or flat TIC pattern on dynamic contrast-enhanced MR images indicates benign disease, but there is added value from including the ADC value in the evaluation of tumors that show a plateau or washout TIC pattern. (C) RSNA, 2008
引用
收藏
页码:909 / 916
页数:8
相关论文
共 21 条
[1]  
Al-Khafaji BM, 1998, CANCER CYTOPATHOL, V84, P153, DOI 10.1002/(SICI)1097-0142(19980625)84:3<153::AID-CNCR6>3.3.CO
[2]  
2-7
[3]  
Eida S, 2007, AM J NEURORADIOL, V28, P116
[4]   MALIGNANT PAROTID TUMORS - CLINICAL USE OF MR IMAGING AND HISTOLOGIC CORRELATION [J].
FRELING, NJM ;
MOLENAAR, WM ;
VERMEY, A ;
MOOYAART, EL ;
PANDERS, AK ;
ANNYAS, AA ;
THIJN, CJP .
RADIOLOGY, 1992, 185 (03) :691-696
[5]   Diffusion-weighted echo-planar MRI: A valuable tool for differentiating primary parotid gland tumors? [J].
Habermann, CR ;
Gossrau, P ;
Graessner, J ;
Arndt, C ;
Cramer, MC ;
Reitmeier, F ;
Jaehne, M ;
Habermann, CR .
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2005, 177 (07) :940-945
[6]   TREATMENT OF WARTHINS TUMOR BY ENUCLEATION [J].
HELLER, KS ;
ATTIE, JN .
AMERICAN JOURNAL OF SURGERY, 1988, 156 (04) :294-296
[7]  
Ikeda M, 2004, AM J NEURORADIOL, V25, P1256
[8]  
Lev MH, 1998, AM J NEURORADIOL, V19, P1835
[9]  
Motoori K, 2005, AM J NEURORADIOL, V26, P1201
[10]   Role of salivary gland scintigraphy with Tc-99m pertechnetate in determining treatment of solitary parotid gland tumors: A retrospective study [J].
Nakahara, Tadaki ;
Suzuki, Takayuki ;
Hashimoto, Jun ;
Shigematsu, Naoyuki ;
Tomita, Toshiki ;
Ogawa, Kaoru ;
Kubo, Atsushi .
CLINICAL NUCLEAR MEDICINE, 2007, 32 (05) :363-366